Skip to main content

par 209 par 209 (Propafenone Hydrochloride Extended Release 225 mg)

Pill with imprint par 209 par 209 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended Release 225 mg. It is supplied by AvKARE, Inc.

Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for par 209 par 209

Propafenone Hydrochloride Extended Release

par 209 par 209
225 mg
22.00 mm
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
AvKARE, Inc.
National Drug Code (NDC)
Inactive Ingredients
ethylcellulose, lactose anhydrous, magnesium stearate, povidone, titanium dioxide, gelatin, D&C Yellow No. 10, ferrosoferric oxide, butyl alcohol, propylene glycol, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "par 209 par 209"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.